Astellas Sues To Block Hospira's Generic Adenoscan
Astellas and subsidiary Item Development AB said Hospira had filed an Abbreviated New Drug Application for a generic version of adenosine, an injectable fluid that replicates the stress placed on the heart during strenuous activity to allow for cardiac stress testing in patients physically unable to exercise.
If approved by the...
Already a subscriber? Click here to login